The Food and Drug Administration (FDA) has approved the Autus Size-Adjustable Valve (Edward Lifesciences) for pediatric patients with congenital heart ...
Polypharmacy involving prescription medications affected more than one-third of older adults in 2021 to 2023, according to a ...
Chronic pain was most common patient-reported qualifying condition, accounting for 64.5 and 31.9% in 2016 and 2024.
Federal prosecutors have charged 2 people in an alleged scheme to bring fake versions of the type 2 diabetes drug Ozempic from China and sell them to US distrib ...
The expanded indication for mavacamten offers a novel targeted medical therapy for pediatric patients aged 12 years and older with symptomatic oHCM, backed by data from the phase 3 SCOUT-HCM trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results